Argenx
ARGX
#557
Rank
HK$278.67 B
Marketcap
HK$4,517
Share price
-1.73%
Change (1 day)
51.23%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -HK$32.59

According to Argenx 's latest financial reports the company's current EPS (TTM) is -HK$32.33. In 2022 the company made an earnings per share (EPS) of -HK$101.96.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$32.59-68.04%
2022-HK$101.96